Empower Clinics has received confirmation from the British Columbia Securities Commission that a revocation order will be issued and published on July 29th, 2020
VANCOUVER, BC / ACCESSWIRE / July 29, 2020 / EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (OTCQB: EPWCF) (“Empower” or the “Company“), a life sciences company, is pleased to announce the British Columbia Securities Commission has communicated that the current Cease Trade Order (CTO) is scheduled to be revoked, and a revocation order will be issued and published on July 29th, 2020.
“We confirm that Full Year 2019 and First Quarter 2020 Financial Statements and MD&A and have been filed on SEDAR and the CSE.” said Steven McAuley, Chairman and CEO. “We continue to serve our patients, protect our staff and grow our business, to provide ongoing shareholder value.”
Why M2Bio Sciences | WUHN is a stock to watch ? SEE HERE
Sign up for MORE news updates !
This article is written and published by The Cannabis Stock
Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best articles and news on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result. The Cannabis Stock are engaged in the business of marketing and advertising companies
The Cannabis Stock and its employees may from time to time own shares of the companies named in the articles. All the facts reported by the cannabis stock are information that comes directly from the companies, from their website or on Sedar and are only published as information.